The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
The rise of COVID-19 has fast-tracked the call for innovative clinical trial solutions and about whether the traditional Sponsor-PI-Patient centric model is sustainable. Discussions of an alternative model, hybrid clinical trials, would combine elements of both centralized and decentralized systems while also leaving the door open for new technologies. But what should the patient experience in a proposed hybrid model? What could the role of advanced technology such as AI, digital patient recruitment and mobile apps be? How would decision making and stakeholder collaboration be impacted? Explore these issues and discuss best practices you can implement in 2021.
Learning Objectives:
Identify the feasibility and best practices of hybrid clinical trials.
List solutions, methods and possible standards that hybrid clinical trials offer which can still result in desirable outcomes.
Gain an understanding of what roles and challenges different stakeholders face when it comes to hybrid clinical trials.
Speaker(s):
Al
Pacino,
President & CEO,
BlueCloud by HealthCarePoint
Credits
1.00
- ACRP Credits
You must be logged in and own this session in order to
post comments.
Regina Ingram
4/6/21 3:07 pm
This was an excellent course.
Sarah Wood
5/13/21 3:49 pm
This was very informative and well presented.
Mbayang Dibba
9/28/21 7:27 am
Thank you for an excellent presentation.
Karli Andy
10/4/21 11:42 am
Great info here and impressed with presenter's ability to handle all the questions~
Regina Ingram
4/6/21 3:07 pm
This was an excellent course.